| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -8.7e-05 | 1 |